DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Spec A, Pullman J, Thompson GR. , et al; Mycoses Study Group.
MSG-10: a phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.
J Antimicrob Chemother 2019;
74 (10) 3056-3062
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.